Satoshi Motoya

Evidence-based clinical practice guidelines for inflammatory bowel disease

Katsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno et al. · Journal of Gastroenterology · 2018 · 684 citations · Full text

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Takayuki Matsumoto, Satoshi Motoya, Kenji Watanabe et al. · Journal of Crohn s and Colitis · 2016 · 234 citations · Full text

Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease

Ryan C. Ungaro, Clara Yzet, Peter Bossuyt et al. · Gastroenterology · 2020 · 227 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Deep Remission +8

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai et al. · Journal of Gastroenterology · 2013 · 162 citations · Full text

A Genome-Wide Association Study Identifies 2 Susceptibility Loci for Crohn's Disease in a Japanese Population

Keiko Yamazaki, Junji Umeno, Atsushi Takahashi et al. · Gastroenterology · 2012 · 138 citations

Genome-wide Association Study, Disease Susceptibility, Pathogenesis +10